THE EFFECTS OF LEVAMISOLE ON SOME FUNCTIONS OF MOUSE MACROPHAGES AFTER INVITRO AND INVIVO ADMINISTRATION

被引:13
作者
CRUCHAUD, A [1 ]
BERNEY, M [1 ]
WELSCHER, HD [1 ]
机构
[1] UNIV GENEVA, HOP CANTONAL,SCH MED,DEPT MED, DIV IMMUNOL & ALLERGOL,WILSDORF LAB, CH-1211 GENEVA 4, SWITZERLAND
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1979年 / 1卷 / 01期
关键词
D O I
10.1016/0192-0561(79)90030-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In vitro incubation of peritoneal macrophages from normal, peptone-stimulated mice with levamisole (1-100 μM) for 1 and 22 h had no effect on either phagocytosis of particulate material (sheep erythrocytes, zymosan) or cellular levels and release of lysosomal enzymes (β-d-glucuronidase, cathepsin D). By contrast, levamisole 1 and 5 mM dramatically increased enzyme release while inhibiting phagocytosis. In some experiments, however, these high concentrations of levamisole caused an elevated cell mortality. When incubation was extended to 72 h, a decrease of both phagocytosis and enzyme release was observed. The catabolism of endocytosed antigens (sheep erythrocytes, human gammaglobulin) was not at all or only slightly modified depending upon the antigen. The cellular level of cyclic AMP remained unchanged in all experiments. In vivo exposure of macrophages to levamisole (2.5 and 10 mg/kg/day i.p. for 3 days) produced a dose-dependent increase in processing of endocytosed antigens asshown by an enhanced transfer of initially endocytosed material to the macrophage plasma membrane. The other parameters were not modified. The immunogenicity of erythrocytes, when endocytosed by levamisole-treated macrophages and transferred into unsensitized recipients, was increased in some in vivo experiments. © 1979.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 39 条
  • [1] CONCENTRATIONS OF LEVAMISOLE REQUIRED FOR ENHANCED PROLIFERATION OF HUMAN LYMPHOCYTES AND PHAGOCYTOSIS BY MACROPHAGES
    ALIBRAHIM, MS
    HOLZMAN, RS
    LAWRENCE, HS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1977, 135 (04) : 517 - 523
  • [2] ALIBRAHIM MS, 1977, IMMUNE MODULATION CO, P39
  • [3] ANDERSON R, 1976, J IMMUNOL, V117, P428
  • [4] COPELAND D, 1974, CANCER CHEMOTH REP 1, V58, P167
  • [5] CRUCHAUD A, 1971, J IMMUNOL, V107, P1329
  • [6] CRUCHAUD A, 1975, J IMMUNOL, V114, P102
  • [7] DEFECTIVE NEUTROPHIL CHEMOTAXIS AND RAISED SERUM IGE LEVELS IN A CHILD WITH RECURRENT BACTERIAL-INFECTIONS AND ECZEMA - INFLUENCE OF LEVAMISOLE
    DECREE, J
    EMMERY, L
    TIMMERMANS, J
    EECKELS, R
    DECOCK, W
    VERHAEGEN, H
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1978, 53 (02) : 144 - 149
  • [9] EFFECTS OF LEVAMISOLE AND IMIDAZOLE ON LYMPHOCYTE-PROLIFERATION AND CYCLIC NUCLEOTIDE LEVELS
    HADDEN, JW
    COFFEY, RG
    HADDEN, EM
    LOPEZCORRALES, E
    SUNSHINE, GH
    [J]. CELLULAR IMMUNOLOGY, 1975, 20 (01) : 98 - 103
  • [10] HOEBEKE J, 1973, J RETICULOENDOTH SOC, V14, P317